Professional Documents
Culture Documents
Novel Strategy For Measuring Creatine Kinase Reaction Rate in The in Vivo Heart
Novel Strategy For Measuring Creatine Kinase Reaction Rate in The in Vivo Heart
Novel Strategy For Measuring Creatine Kinase Reaction Rate in The in Vivo Heart
Novel strategy for measuring creatine kinase reaction rate in the in vivo heart
Qiang Xiong,1 Qinglu Li,1 Abdul Mansoor,1 Mohammad Nurulqadr Jameel,1 Fei Du,2 Wei Chen,2
and Jianyi Zhang1,2
1
Cardiovascular Division, Department of Medicine, and 2Center for Magnetic Resonance Research, Department of Radiology,
University of Minnesota Medical School, Minneapolis, Minnesota
Submitted 14 November 2008; accepted in final form 24 June 2009
as a compensatory response to
various stressors, including pressure overload, volume overload, and myocardial infarction. After a prolonged period of
compensatory hypertrophy with restored ventricular wall
stress, severe ventricular dysfunction often occurs with signs of
congestive heart failure (CHF). The exact mechanisms underlying this transition from compensated ventricular hypertrophy
to CHF are likely multifactorial, but alterations in myocardial
bioenergetics have been considered to be important factors in
this pathway (14, 15). The creatine kinase (CK) enzyme
catalyzes the reaction that converts adenosine diphosphate
(ADP) and phosphocreatine (PCr) to adenosine triphosphate
(ATP) and creatine (Cr) (13). This maintains high ADP levels
in the mitochondria, where ATP is generated, and low ADP
levels at the contractile apparatus, where ATP is utilized, thus
facilitating the production and utilization of ATP (26, 28). Our
laboratory has previously reported that the myocardial CK forward flux rate is significantly reduced in hypertrophied hearts (20,
29 31). The severity of this reduction is linearly related to the
severity of the hypertrophy and left ventricular (LV) dysfunction
(29). Recently, using a low-field 1.5-T magnet, Weiss and associates examined heart failure patients and found that the CK flux
was reduced in patients with LV hypertrophy and CHF (23, 27).
Importantly, the studies demonstrate that the severity of the
reduction in CK flux rate is related to the severity of LV contractile dysfunction (23) and suggest that the CK flux rate may be a
more sensitive myocardial energetic indicator for the severity of
LV dysfunction compared with the PCr-to-ATP ratio in heart
http://www.ajpheart.org
H1011
mont, CA) console. 31P- and 1H-NMR frequencies were 81 and 200
MHz, respectively. Radio-frequency transmission and signal detection
were performed with a 28-mm-diameter double-tuned surface coil sutured directly to the epicardium of anterior LV wall. The coil was
cemented to a sheet of silicone rubber 0.7 mm in thickness and 20%
larger in diameter than the coil itself. A capillary containing 15 l of 3 M
phosphonoacetic acid was placed at the coil center to serve as a reference.
The proton signal from water detected with the surface coil was used to
homogenize the magnetic field and to adjust the position of the animal in
the magnet so that the coil was at or near the magnetic isocenter. This was
accomplished using a spin-echo experiment and a readout gradient. The
information gathered in this step was also utilized to determine the spatial
coordinates for spectroscopic localization (10, 17). Chemical shifts were
measured relative to PCr, which was assigned a chemical shift of 2.55 ppm
relative to 85% phosphoric acid at 0 ppm. Baseline myocardial high-energy
phosphate data acquisition was achieved with a 90 adiabatic half-passage
pulse, and selective saturation on ATP- was achieved with B1-insensitive
train to obliterate signal (BISTRO), as previously reported (16).
kf calculation of conventional MST methods. Table 1 summarizes
all of the abbreviations and symbols.
A conventional MST method consists of two experiments, namely,
progressive and steady-state saturations. The CK enzyme catalyzes
the reaction PCr ADP H k^f Cr ATP. The progressive
saturation transfer experiment employs multiple data acquisitions with
progressively prolonged saturation on ATP- to retrieve the apparent
relaxation time constant of PCr by fitting its signal intensity to the
following equation (2):
app
M PCrt M0,PCr T 1,PCr
kf exp
app
T 1,PCr
app
T 1,PCr
int
T1,PCr
(1)
MST
MRS
CK
d1
d2
FID
kf
M0
Mshort
Mss
MTR,PCr
nt
T app
1
T mix
1
TR
p31
Gx
Gy
Gz
d2
d1
(2)
MPCr
M0,PCr
app
T1,PCr
(3)
MPCr
Mss,PCr
int
T1,PCr
(4)
int
dt
T1,PCr
t 0, d1
dMATPt M0,ATP MATPt
kfMPCrt krMATPt
int
dt
T1,ATP
(6)
int
t d1, d1d2
dt
T1,PCr
MATPt 0
(7)
(8)
www.ajpheart.org
H1012
Tapp
1,PCr
int
T 1,PCr
M0,PCr
int
1T 1,PCr
kf
(9)
deviation
deviation
deviation
deviation
tional method, where long d1 would be employed (Fig. 2A). The short
d1 strategy can offer great reduction of TR. In case of a very limited
time window for MST experiment, only one spectrum with ATP-
saturated is needed in addition to Mss,PCr measurement to unambiguapp
, according to the following equation:
ously solve the T1,PCr
app
TR/ln1 MTR,PCr /Mss,PCr
T 1,PCr
(10)
www.ajpheart.org
H1013
int
Fig. 4. Spectra obtained for T1,PCr
calculation.
int
T1,PCr
was estimated from Spencers method
(11) using two spectra: Mshort,PCr [TR 0.3 s,
number of averaged FIDs for one spectrum
(nt) 480] (A) and M0,PCr (TR 12 s, nt
12) (B). The vertical scale of A is 15 times that
of B, and a larger data acquisition number was
employed in A for better illustration of the
spectra. Both spectra were obtained with a total
acquisition time of 2.4 min. The spectra
int
yielded a T1,PCr
value of 4 s, according to Eq.
14. 2,3-DPG, 2,3-diphosphoglycerate. See text
for definition of terms.
mix
int
lnT1,PCr
kf1 1
d 1,ideal T 1,PCr
RESULTS
(11)
(12)
mix
1,PCr
where T
is the approximate apparent relaxation time of PCr
undergoing chemical exchanges with ATP- and depends on
int
int
T1,PCr
, T1,ATP
, M0,PCr/M0,ATP, and kf. By combining Eqs. 10
12, the ideal presaturation delay can be calculated as:
(13)
www.ajpheart.org
H1014
int
TRshort ln 1
T 1,PCr
Mshort,PCr
M0,PCr
(14)
where TRshort and Mshort,PCr stand for the TR and PCr signal
intensity of spectrum 4A, respectively. The calculation resulted
int
int
in an estimated T1,PCr
of 4 s; therefore, a T1,PCr
value of 4.5 s
(10% overestimation based on the mathematical simulation to
int
compensate the possible errors in T1,PCr
measurement) was
employed to calculate the d1,opt and d2,opt. Other parameters
used in calculation are as follows: kf (0.2, 0.8) s1, M0,PCr/
int
int
M0,ATP 2, and T1,PCr
/T1,ATP
3. The calculation yielded a
d1,opt value of 2 s and a d2,opt of 3.3 s. To compensate possible
int
int
deviations in M0,PCr/M0,ATP and T1,PCr
/T1,ATP
estimation, a
saturation time of 3.5 s was applied based on the mathematical
simulation. The spectra obtained with d1,opt and conventional
strategies are shown in Fig. 5. There was no detectable difference in Mss,PCr measurement between the d1,opt and the conventional strategies (Fig. 5, B1B3). However, substantial
reductions in saturation time (56%) and total TR (73%) were
granted by using the d1,opt strategy. A control spectrum (Fig. 5,
A2) with saturation pulse set downfield to PCr symmetrically
opposite from ATP- was also acquired. By comparing it with
Table 2. Comparison of measurements between novel and
conventional MST strategies from the same hearts of
four pigs
Strategy
M0,PCr
Mss,PCr/M0,PCr
app
T1,PCr
,s
app
T1,PCr
,s
kf, s
Conventional
Novel
0.650.01
0.650.01
1.530.05
1.560.08
4.30.2
4.40.2
0.420.01
0.420.03
www.ajpheart.org
H1015
M0 and Mss,
TR nt, s
app
T1,PCr
, TR
nt np, s
kf, min
Conventional
Novel
(12 20) 12
(12 5.5) 12
14.6 12 6
1.5 30 1
23.9
4.3
app
T1,PCr
was calculated from curve fitting of 6 time points (np 6). In the
conventional approach, 14.6 is the average TR for 6 points. All points were
acquired with 12 averaged FIDs (nt 12). In the novel approach, only TR
app
1.5 s spectrum (nt 30, Fig. 6C3) was used to calculate T1,PCr
, together with
Mss measurement (nt 12, Fig. 5B2), according to Eq. 10.
2A, A1
3A, A
M0,PCr
M0,PCr
app
1,PCr
Mss,PCr
(15)
M0,PCr
int
T1,PCr
,s
int
T1,ATP
,s
kf, s1
5
2
9
6
20
29
30
19
27
2.5
2.06
2.7
2.78
2.2
2.02
3.75
5.3
NA
0.8
0.75
0.9
0.99
NA
NA
NA
2.7
NA
0.67
0.271.3
0.84
NA
0.20.41
0.310.49
0.57
NA
0.210.32
A3, B
Fig. 8. Flow chart showing each data acquisition step in implementing the
novel MST strategy. Bold boxes indicate the actual measurements from
spectra. MST protocol: the implement of novel MST strategy for noninvasive creatine kinase (CK) flux rate measurement of any solid organs. All
spectra are acquired with 90 flip angle. (1) Take scout images (Fig. A1, left)
to guild the spatial localization of the spectroscopy. Choose the region of
interest, and take a scout spectrum (Fig. A1A). Number of averaged FIDs for
each spectrum is determined here according to signal-to-noise ratio (SNR). The
scout spectrum also provides the frequency offset information for the saturation pulse. The TR for scout spectra can be varied according to best SNR per
unit acquisition time. (2) Take M0,PCr measurement (Fig. A2A1) with the same
spatial localization parameters as used in scout spectrum. The TR for M0,PCr
measurement is usually 918 s, depending on the allowed data acquisition
window. (3) Take Mshort,PCr measurement with very short repetition time
int
using
(TR 0.3 s). (4) Combine step 2 and 3 measurements to calculate T1,PCr
Eq. 14. Note that we only need to make this measurement for an initial few
int
subjects, because the T1,PCr is considered as a constant and is independent of
physiological conditions. (5) Estimate a viable kf range, then combine it with
int
value to calculate d1,opt and d2,opt via numerical simulation of Eqs.
the T1,PCr
5 8. TR d1,opt d2,opt. (6) Take Mss,PCr measurement (Fig. A3A) using TR
from step 5. (7) Take MTR,PCr measurement (Fig. A3B) with ATP- continuously saturated. The TR here can be arbitrary according to Eq. 10. The SNR
per unit acquisition time can be maximized if the TR is chosen to be around
app
T1,PCr
. (8) Calculate M/M0 from step 2 and 6 measurements. (9) Calculate
app
from steps 6 and 7 measurements using Eq. 10. (10) Combine results
T1,PCr
from steps 8 and 9 to calculate kf using Eq. 3.
int
T1,ATP
,s
int
T1,ATP
,s
kf,CK, s1
Values
4.0
1.33
0.15 0.6
See Ref. 7.
www.ajpheart.org
H1016
Fig. A2. Experimental validation of d1,opt strategy on rat brain. All spectra were acquired with 3D-ISIS pulse sequence and 128 averaged FIDs. A1 is M0,PCr
measurement (TR 9 s); A2 is the control spectrum with saturation pulse set downfield from PCr symmetrically opposite from ATP-; spectrum A3 A1
A2, from which we can see there is no spillover effect of the BISTRO saturation pulse. Spectra B1 and B3 are Mss,PCr measurements using conventional (d1
9 s, d2 8 s) and novel (d1 d1,opt 2.1 s, d2 d2,opt 3.4 s) strategies, respectively. Spectrum B2 was acquired with TR d1,opt 2.1 s and saturation
pulse off. Spectrum B4 B3 B1. The bold arrows indicate the frequency of saturation pulses. Total acquisition times for spectra A1, A2, B1, B2, and B3 were
19.2, 36.3, 36.3, 4.5, and 11.7 min, respectively.
AJP-Heart Circ Physiol VOL
www.ajpheart.org
H1017
app
Fig. A3. T1,PCr
measurement from two spectra. Spectrum A is the Mss,PCr measurement
(same as spectrum B3 in Fig. A2). Spectrum
B was acquired with ATP- continuously
saturated and relatively shorter TR (TR
1.4 s, nt 512). Total acquisition times for
spectra A and B were 11.7 and 11.9 min,
app
respectively. T1,PCr
is calculated using Eq.
app
10: T1,PCr
TR/ln(1 MTR,PCr/Mss,PCr).
effect on PCr peak of the saturation pulse train and thus better
SNR for quantification. In the present study, the novel strategy,
together with BISTRO saturation pulse train, yielded no detectable spillover effect on PCr peak (Fig. 5A). Consequently,
the control spectrum usually employed in other MST studies
(25, 29) can be eliminated. A second benefit from the reduced
saturation time is related to the specific absorption rate issue
when human subjects are involved. The minimal saturation
time provided by d1,opt strategy can, to a large extent, relieve
the Food and Drug Administration concerns on heat generation
by long duration of saturation pulse train employed in conventional MST strategy.
Other merits of the novel strategy. Recently, an important
four-angle saturation transfer method has been developed and
utilized for measuring CK reaction rates in humans (4, 23, 27).
app
This method employs a short TR (TR T1,PCr
) and different
app
flip angles to calculate the M0,PCr, Mss,PCr, and T1,PCr
. This
method is very time efficient, and better SNR within a given
data acquisition time can be achieved by flip angle optimizaapp
tion. However, the M0,PCr, Mss,PCr, and T1,PCr
calculations of the
four-angle saturation transfer method heavily rely on the accuracy of designed flip angles. This could potentially be
difficult at a higher field because of the characteristics of B1
penetration in high field magnet. A homogeneous flip angle
may not be achieved at high field, even though adiabatic pulses
such as BIR4 or BIRP are employed. The novel strategy
demonstrated in the present study, as an alternative method,
can provide the following advantages, in addition to reductions in TR and saturation time. Both M0,PCr and Mss,PCr are
directly measured, which enables the simple calculation of
app
kf and insensitivity to flip angle variation. For T1,PCr
calculation, the novel strategy requires only one ATP--saturated
spectrum (Fig. 6, C3) in addition to Mss,PCr measurement,
according to Eq. 10. The TR for ATP--saturated spectrum can
be arbitrary, and maximum SNR per unit time can be achieved
app
by a simple 90 readout pulse, if TR is chosen to be around T1,PCr
.
(When ATP- is saturated, PCr magnetization relaxes accordapp
app
ing to T1,PCr
, and thus Ernst angle will be 90 if TR T1,PCr
).
Validity of the methodology. The validity of the new methodology was tested in a pig heart model. The results from the
novel strategy were the same as for the conventional MST
app
method with long presaturation delay (Table 2). The T1,PCr
values retrieved from d1 of 0- and 7-s curves were identical
AJP-Heart Circ Physiol VOL
Source
This work (n 6)
Literature (7)
int
T1,PCr
,s
kf,CK, s1
Acquisition
Time, min
0.220.02
0.240.02
43*
180
www.ajpheart.org
H1018
Objective
This appendix serves to demonstrate that the novel MST strategy is
compatible with spatial localization of 3D-ISIS pulse sequence for
noninvasive measurement of ATP production rate via CK. The total
data acquisition time was decreased by 76% compared with conventional MST methods.
Methods
Animal preparation. The experiments were performed using a rat
brain model, and details of animal preparation for 31P-MRS have been
described previously (7). Briefly, rats were anaesthetized via inhalation of 2% isofluorane, intubated, and ventilated by a mechanical
respirator. The femoral artery and vein were catheterized for blood
sampling and monitoring of physiological parameters. The rectal
temperatures were maintained at 37 1C throughout the experiment
with an external heating patch.
In vivo 31P-MRS experiments. All in vivo 31P-MRS experiments
were conducted on a 9.4-T horizontal animal magnet (Magnex Scientific) interfaced with a Varian INOVA console. A multinuclear
radio-frequency surface-coil probe, consisting of a butterfly-shaped
1
H surface coil and an elliptical-shaped 31P surface coil with axes of
12 mm and 10 mm, was used. The 1H surface coil was used to acquire
anatomical images of the brain to guide choosing the regions of
interest and for shimming magnetic field homogeneity. For 31P spectroscopy, a 3D-ISIS pulse sequence was used for spatial localization.
BISTRO pulse train was used to achieve frequency selective saturation, and an adiabatic half-passage pulse was used for readout. To help
visualize whether the spatial localization was adequate, two capillaries
filled with 10% phosphoric acid were inserted into the skeletal muscle
surrounding the skull.
The optimized MST strategy. The d1,opt strategy was employed
for Mss,PCr measurement. The parameters used for calculating d1,opt
and d2,opt were from literature (7) and are summarized in Table A1.
Those parameters gave rise to a d1,opt value of 2.1 s and d2,opt of 3.4 s.
app
measurement, a short-TR (TR 1.4 s) spectrum with
For T1,PCr
continuous saturation of ATP- was performed and used in combiapp
nation with Mss,PCr measurement to calculate the T1,PCr
, according to
Eq. 10.
Results
Spatial localization of 3D-ISIS sequence. A demonstration of
spatial localization of 3D-ISIS pulse sequence is shown in Fig. A1.
The spatial localization from 3D-ISIS pulse sequence is demonstrated
by the following observations: 1) no detectable phantom signal in
brain region (spectrum A); 2) the obvious low and high PCr-to-ATP
ratios (PCr/ATP) in spectra A and B that are characteristic of brain
and skeletal muscle, respectively.
Validation of novel MST strategy in rat brain model. First,
the d1,opt strategy was validated. The spectra with d1,opt and conventional strategies for M0,PCr and Mss,PCr measurements are shown in
Fig. A2. There was no detectable difference in Mss,PCr measurement
between the d1,opt and the conventional strategies (Fig. A2, B). An
extra spectrum (Fig. A2, B2) with TR d1,opt and saturation pulse off
was also acquired to further confirm the d1,opt strategy. Spectrum B2
generated a PCr signal very close to Mss,PCr measured in B1 and B3,
AJP-Heart Circ Physiol VOL
Conclusion
We have successfully demonstrated the compatibility of the novel
MST strategy with the 3D-ISIS spatial localization and an external
coil for completely noninvasive MST measurement. The strategy was
validated using a rat brain model, which generates a kf measurement
similar to the reported value with only 24% of total data acquisition
time compared with the conventional approach.
GRANTS
This work was supported by US Public Health Service Grants. M. N.
Jameel was supported by American Heart Association Greater Midwest Predoctoral Award no. 0810015Z.
REFERENCES
1. Bittl JA, Balschi JA, Ingwall JS. Effects of norepinephrine infusion on
myocardial high-energy phosphate content and turnover in the living rat.
J Clin Invest 79: 18521859, 1987.
2. Bittl JA, Ingwall JS. Reaction rates of creatine kinase and ATP synthesis
in the isolated rat heart. J Biol Chem 260: 35123517, 1985.
3. Bloch F. Nuclear induction. Phys Rev 70: 460 474, 1946.
4. Bottomley PA, Ouwerkerk R, Lee RF, Weiss RG. Four-angle saturation
transfer (FAST) method for measuring creatine kinase reaction rates in
vivo. Magn Reson Med 47: 850 863, 2002.
5. Degani H, Laughlin M, Campbell S, Shulman R. Kinetics of creatine
kinase in heart: a 31P NMR saturation- and inversion-transfer study.
Biochemistry 24: 5510 5516, 1985.
6. Dobson GP, Veech RL, Passonneau JV, Kobayashi K, Inubushi T,
Wehrli S, Nioka S, Chance B. 31P NMR and enzymatic analysis of
cytosolic phosphocreatine, ATP, Pi and intracellular pH in the isolated
working perfused rat heart. NMR Biomed 5: 20 28, 1992.
7. Du F, Zhu XH, Zhang Y, Friedman M, Zhang NY, Ugurbil K, Chen
W. Tightly coupled brain activity and cerebral ATP metabolic rate. Proc
Natl Acad Sci USA 105: 6409 6414, 2007.
8. Friedrich J, Nascimben L, Liao R, Ingwall JS. Phosphocreatine TI
measurements with and without exchange in the heart. Magn Reson Med
30: 4550, 1993.
9. Goudemant JF, vander Elst L, Dupont B, Van Haverbeke Y, Muller
RN. pH and temperature effects on kinetics of creatine kinase in aqueous
solution and in isovolumic perfused heart. A 31P nuclear magnetization
transfer study. NMR Biomed 7: 101110, 1994.
10. Hendrich K, Merkle H, Weisdorf S, Vine W, Garwood M, Ugurbil K.
Phase-modulated rotating frame spectroscopic localization using an adiabatic plane-rotation pulse and single surface coil. J Magn Reson 92:
258 275, 1991.
11. Horska A, Horsky J, Spencer RGS. Measurement of spin-lattice relaxation times in systems undergoing chemical exchange. J Magn Reson 110:
82 89, 1994.
12. Hu Q, Wang X, Lee J, Mansoor A, Liu J, Zeng L, Swingen C, Zhang
G, Feygin J, Ochiai K, Bransford TL, From AH, Bache RJ, Zhang J.
Profound bioenergetic abnormalities in peri-infarct myocardial regions.
Am J Physiol Heart Circ Physiol 291: H648 H657, 2006.
13. Ingwall JS, Kramer MF, Fifer MA, Lorell BH, Shemin R, Grossman
W, Allen PD. The creatine kinase system in normal and diseased human
myocardium. N Engl J Med 313: 1050 1054, 1985.
14. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using
chemical energy to support cardiac function. Circ Res 95: 135145, 2004.
www.ajpheart.org
H1019
25. Ugurbil K, Petein M, Maidan R, Mishurshi S, From AHL. Measurement of an individual rate constant in the presence of multiple exchanges:
application to myocardial creatine kinase reaction. Biochemistry 25: 100
107, 1986.
26. Ventura-Clapier R, Saks VA, Vassort G, Lauer C, Elizarova GV.
Reversible MM-creatine kinase binding to cardiac myofibrils. Am J
Physiol Cell Physiol 253: C444 C455, 1987.
27. Weiss RG, Gerstenblith G, Bottomley PA. ATP flux through creatine
kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci
USA 102: 808 813, 2005.
28. Wyss M, Smeitink J, Wevers RA, Wallimann T. Mitochondrial creatine
kinase: a key enzyme of aerobic energy metabolism. Biochim Biophys
Acta 1102: 119 166, 1992.
29. Ye Y, Gong GR, Ochiai K, Liu JB, Zhang JY. High-energy phosphate
metabolism and creatine kinase in failing hearts : a new porcine model.
Circulation 103: 1570 1576, 2001.
30. Ye Y, Wang CS, Zhang JY, Cho YK, Gong GR, Murakami M, Bache
RJ. Myocardial creatine kinase kinetics and isoform expression in hearts
with severe LV hypertrophy. Am J Physiol Heart Circ Physiol 281:
H376 H386, 2001.
31. Zhang JY. Myocardial energetics in cardiac hypertrophy. Clin Exp
Pharmacol Physiol 29: 351359, 2002.
32. Zhang JY, Merkle H, Hendrich K, Garwood M, From AHL, Ugurbil
K, Bache RJ. Bioenergetic abnormalities associated with severe leftventricular hypertrophy. J Clin Invest 92: 9931003, 1993.
33. Zhang JY, Wilke N, Wang Y, Zhang Y, Wang CS, Eijgelshoven MHJ,
Cho YK, Murakami Y, Ugurbil K, Bache RJ, From AHL. Functional
and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine modelMRI and P-31-MRS study. Circulation 94:
1089 1100, 1996.
www.ajpheart.org